Corrigendum to: The Hepatoprotective Effects of Ginsenoside from Ginseng: A Review of Molecular Mechanisms and Therapeutic Potentials

In the originally published article [1], a phrase was unclear, which may have affected readability. This has now been revised to improve clarity and ensure that the intended meaning is accurately conveyed. The corrections do not affect the results, interpretations, or conclusions of the article. The original article can be found online at: https://www.eurekaselect.com/article/138842 Details of the error and its correction are provided below: ORIGINAL: Abstract: Treatment of hepatic diseases presents a significant challenge due to their diverse nature. Ginsenosides, bioactive compounds derived from the root of Panax ginseng and widely used in traditional Chinese medicine, offer multifaceted protection to various organs in the body. Their versatile effects, including antioxidant, anti-inflammatory, anti-apoptotic and more, make them a promising approach for addressing hepatic disorders. This review explores the intricate molecular mechanisms and properties of ginsenosides in the prevention and treatment of liver ailments, from mild conditions to severe damage and liver fibrosis. Given the increasing prevalence of hepatic disorders, this article sheds light on the significant pharmaceutical potential of ginsenosides in the realm of hepatic disease management. CORRECTED: Abstract: Treatment of hepatic diseases presents a significant challenge due to their diverse nature. Ginsenosides, bioactive compounds derived from the root of Panax ginseng and widely used in traditional Chinese medicine, offer multifaceted protection to various organs in the body. Their versatile effects, including antioxidant, anti-inflammatory, anti-apoptotic and more, make them a promising approach for addressing hepatic disorders. This review explores the intricate molecular mechanisms and properties of ginsenosides in the prevention and treatment of liver diseases, from mild conditions to severe damage and liver fibrosis. Given the increasing prevalence of hepatic disorders, this article sheds light on the significant pharmaceutical potential of ginsenosides in the realm of hepatic disease management. ORIGINAL: Ginsenosides refer to a collection of bioactive substances discovered in the root of Panax ginseng, a medicinal plant that has been employed in traditional Chinese medicine for many centuries [8]. The medicinal properties of ginseng have been extensively documented in the fields of the central nervous, cardiovascular, endocrine, and immune systems. Furthermore, it exhibits anti-cancer, anti-stress, and antioxidant properties [9, 10]. Even the protective effects of ginseng against coronavirus disease 2019 (COVID-19) have been recently reported [11]. The positive impacts of ginseng can be credited to its diverse array of pharmacologically active constituents; however, the majority of its pharmacological benefits are linked to ginsenosides [12]. Studies have extensively explored the hepatoprotective properties of ginsenosides, ranging from mild to severe liver damage with various etiologies and liver fibrosis. In this review, we provide a summary of the present knowledge and recent advancements regarding the effects of ginsenosides in mitigating various liver ailments. CORRECTED: Ginsenosides refer to a collection of bioactive substances discovered in the root of Panax ginseng, a medicinal plant that has been employed in traditional Chinese medicine for many centuries [8]. The medicinal properties of ginseng have been extensively documented in the fields of the central nervous, cardiovascular, endocrine, and immune systems. Furthermore, it exhibits anti-cancer, anti-stress, and antioxidant properties [9, 10]. Even the protective effects of ginseng against coronavirus disease 2019 (COVID-19) have been recently reported [11]. The positive impacts of ginseng can be credited to its diverse array of pharmacologically active constituents; however, the majority of its pharmacological benefits are linked to ginsenosides [12]. Studies have extensively explored the hepatoprotective properties of ginsenosides, ranging from mild to severe liver damage with various etiologies and liver fibrosis. In this review, we provide a summary of the present knowledge and recent advancements regarding the effects of ginsenosides in mitigating various liver diseases. The publishers apologize for any inconvenience caused.